BridgeBio Oncology Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $448.4M
Liabilities Breakdown FY2025
Total Liabilities: $37.3M
Asset Breakdown
Total Assets: $448.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $373.7M | 83.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $956.0K | 0.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $73.7M | 16.4% |
Liabilities Breakdown
Total Liabilities: $37.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 3.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $35.9M | 96.3% |